ID   LIV27
AC   CVCL_C4LN
DR   Wikidata; Q116049708
RX   PubMed=26956050;
RX   PubMed=36291862;
CC   Population: Caucasian.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Characteristics: Highly tumorigenic.
CC   Doubling time: 57.8 hours (Note=At 14th passage) (PubMed=36291862).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=36291862
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 8,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 8,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=36291862; DOI=10.3390/cancers14205080; PMCID=PMC9600735;
RA   Ding, Xi-Wei
RA   Zakharia, Kais
RA   Moser, Catherine D.
RA   Campbell, Nellie A.
RA   Hu, Chun-Ling
RA   Razumilava, Nataliya
RA   Chaiteerakij, Roongruedee
RA   Shaleh, Hassan M.
RA   Greipp, Patricia T.
RA   Graham, Rondell Patrell
RA   Zou, Xiao-Ping
RA   Chandan, Vishal Suresh
RA   Roberts, Lewis Rowland
RT   "Establishment and characterization of a new human intrahepatic
RT   cholangiocarcinoma cell line LIV27.";
RL   Cancers (Basel) 14:5080.1-5080.10(2022).
//
RX   PubMed=26956050; DOI=10.18632/oncotarget.7914; PMCID=PMC4991440;
RA   Ding, Xi-Wei
RA   Chaiteerakij, Roongruedee
RA   Moser, Catherine D.
RA   Shaleh, Hassan M.
RA   Boakye, Jeffrey
RA   Chen, Gang
RA   Ndzengue, Albert
RA   Li, Ying
RA   Zhou, Yan-Ling
RA   Huang, Sheng-Bing
RA   Sinicrope, Frank A.
RA   Zou, Xiao-Ping
RA   Thomas, Melanie Byrne
RA   Smith, Charles D.
RA   Roberts, Lewis Rowland
RT   "Antitumor effect of the novel sphingosine kinase 2 inhibitor
RT   ABC294640 is enhanced by inhibition of autophagy and by sorafenib in
RT   human cholangiocarcinoma cells.";
RL   Oncotarget 7:20080-20092(2016).
//